![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
The Kentucky Viral Hepatitis Treatment Project (KeY Treat): Preliminary Outcomes from a Phase 4 Clinical Trial in Rural Appalachia
|
|
|
AASLD 2022 Nov 4-8
Jennifer Havens, PhD1; Takako Schaninger, MD2; Michelle Lofwall, MD1, Hannah Fraser, PhD3, Peter Vickerman, DPhil3, Sharon Walsh, PhD1
1Center on Drug and Alcohol Research 2Division of Infectious Diseases, University of Kentucky College of Medicine, Lexington KY, USA 3 Bristol Medical School, Bristol Medical School, Bristol, UK
![1109221](../images/110922/110922-2/1109221.gif)
![1109222](../images/110922/110922-2/1109222.gif)
![1109223](../images/110922/110922-2/1109223.gif)
![1109224](../images/110922/110922-2/1109224.gif)
![1109225](../images/110922/110922-2/1109225.gif)
![1109226](../images/110922/110922-2/1109226.gif)
![1109227](../images/110922/110922-2/1109227.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|